COMPASS PATHWAYS PLC Increase (Decrease) in Prepaid Expense and Other Assets
COMPASS PATHWAYS PLC (CMPS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $4.49 million for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2021-03-09
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|
| 2020-12-31 | $4.49M 20-F · filed 2021-03-09 |
| 2019-12-31 | $3.43M 20-F · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |